Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q1 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.